# Plasma Exchange for Renal Vasculitis

> **NCT01408836** · PHASE2,PHASE3 · TERMINATED · sponsor: **Cambridge University Hospitals NHS Foundation Trust** · enrollment: 150 (actual)

## Conditions studied

- Wegener's Granulomatosis
- Microscopic Polyangiitis

## Interventions

- **PROCEDURE:** Plasma exchange
- **DRUG:** Intravenous methyl prednisolone
- **DRUG:** Methyl prednisolone

## Key facts

- **NCT ID:** NCT01408836
- **Lead sponsor:** Cambridge University Hospitals NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1995-03
- **Primary completion:** 2003-06
- **Final completion:** 2003-12
- **Target enrollment:** 150 (ACTUAL)
- **Why stopped:** Completed
- **Last updated:** 2011-08-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01408836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01408836, "Plasma Exchange for Renal Vasculitis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01408836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*